Global Female Contraceptives Market Growth (Status and Outlook) 2025-2031

October 2025 | 89 pages | ID: GBBCFE629F6EN
LP Information

Abstracts

According to this study, the global Female Contraceptives market size will reach US$ 22810 million by 2031.

United States market for Female Contraceptives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Female Contraceptives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Female Contraceptives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Female Contraceptives players cover Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the ?Female Contraceptives Industry Forecast? looks at past sales and reviews total world Female Contraceptives sales in 2024, providing a comprehensive analysis by region and market sector of projected Female Contraceptives sales for 2025 through 2031. With Female Contraceptives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Contraceptives industry.

This Insight Report provides a comprehensive analysis of the global Female Contraceptives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Female Contraceptives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Female Contraceptives market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Contraceptives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Contraceptives.

This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraceptives market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Contraceptive Drugs
• Contraceptive Devices

Segmentation by Application:

• Personal use
• Hospital

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer
• Mayer Laboratories
• Pfizer
• Mylan
• Teva
• Merck
• Johnson & Johnson
• Lupin Pharmaceuticals
• Female Health Company
• Fuji Latex

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Female Contraceptives Market Size (2020-2031)
  2.1.2 Female Contraceptives Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Female Contraceptives by Country/Region (2020, 2024 & 2031)
2.2 Female Contraceptives Segment by Type
  2.2.1 Contraceptive Drugs
  2.2.2 Contraceptive Devices
2.3 Female Contraceptives Market Size by Type
  2.3.1 Female Contraceptives Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Female Contraceptives Market Size Market Share by Type (2020-2025)
2.4 Female Contraceptives Segment by Application
  2.4.1 Personal use
  2.4.2 Hospital
2.5 Female Contraceptives Market Size by Application
  2.5.1 Female Contraceptives Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Female Contraceptives Market Size Market Share by Application (2020-2025)

3 FEMALE CONTRACEPTIVES MARKET SIZE BY PLAYER

3.1 Female Contraceptives Market Size Market Share by Player
  3.1.1 Global Female Contraceptives Revenue by Player (2020-2025)
  3.1.2 Global Female Contraceptives Revenue Market Share by Player (2020-2025)
3.2 Global Female Contraceptives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 FEMALE CONTRACEPTIVES BY REGION

4.1 Female Contraceptives Market Size by Region (2020-2025)
4.2 Global Female Contraceptives Annual Revenue by Country/Region (2020-2025)
4.3 Americas Female Contraceptives Market Size Growth (2020-2025)
4.4 APAC Female Contraceptives Market Size Growth (2020-2025)
4.5 Europe Female Contraceptives Market Size Growth (2020-2025)
4.6 Middle East & Africa Female Contraceptives Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Female Contraceptives Market Size by Country (2020-2025)
5.2 Americas Female Contraceptives Market Size by Type (2020-2025)
5.3 Americas Female Contraceptives Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Female Contraceptives Market Size by Region (2020-2025)
6.2 APAC Female Contraceptives Market Size by Type (2020-2025)
6.3 APAC Female Contraceptives Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Female Contraceptives Market Size by Country (2020-2025)
7.2 Europe Female Contraceptives Market Size by Type (2020-2025)
7.3 Europe Female Contraceptives Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Female Contraceptives by Region (2020-2025)
8.2 Middle East & Africa Female Contraceptives Market Size by Type (2020-2025)
8.3 Middle East & Africa Female Contraceptives Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL FEMALE CONTRACEPTIVES MARKET FORECAST

10.1 Global Female Contraceptives Forecast by Region (2026-2031)
  10.1.1 Global Female Contraceptives Forecast by Region (2026-2031)
  10.1.2 Americas Female Contraceptives Forecast
  10.1.3 APAC Female Contraceptives Forecast
  10.1.4 Europe Female Contraceptives Forecast
  10.1.5 Middle East & Africa Female Contraceptives Forecast
10.2 Americas Female Contraceptives Forecast by Country (2026-2031)
  10.2.1 United States Market Female Contraceptives Forecast
  10.2.2 Canada Market Female Contraceptives Forecast
  10.2.3 Mexico Market Female Contraceptives Forecast
  10.2.4 Brazil Market Female Contraceptives Forecast
10.3 APAC Female Contraceptives Forecast by Region (2026-2031)
  10.3.1 China Female Contraceptives Market Forecast
  10.3.2 Japan Market Female Contraceptives Forecast
  10.3.3 Korea Market Female Contraceptives Forecast
  10.3.4 Southeast Asia Market Female Contraceptives Forecast
  10.3.5 India Market Female Contraceptives Forecast
  10.3.6 Australia Market Female Contraceptives Forecast
10.4 Europe Female Contraceptives Forecast by Country (2026-2031)
  10.4.1 Germany Market Female Contraceptives Forecast
  10.4.2 France Market Female Contraceptives Forecast
  10.4.3 UK Market Female Contraceptives Forecast
  10.4.4 Italy Market Female Contraceptives Forecast
  10.4.5 Russia Market Female Contraceptives Forecast
10.5 Middle East & Africa Female Contraceptives Forecast by Region (2026-2031)
  10.5.1 Egypt Market Female Contraceptives Forecast
  10.5.2 South Africa Market Female Contraceptives Forecast
  10.5.3 Israel Market Female Contraceptives Forecast
  10.5.4 Turkey Market Female Contraceptives Forecast
10.6 Global Female Contraceptives Forecast by Type (2026-2031)
10.7 Global Female Contraceptives Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Female Contraceptives Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Female Contraceptives Product Offered
  11.1.3 Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bayer Main Business Overview
  11.1.5 Bayer Latest Developments
11.2 Mayer Laboratories
  11.2.1 Mayer Laboratories Company Information
  11.2.2 Mayer Laboratories Female Contraceptives Product Offered
  11.2.3 Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Mayer Laboratories Main Business Overview
  11.2.5 Mayer Laboratories Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Female Contraceptives Product Offered
  11.3.3 Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Mylan
  11.4.1 Mylan Company Information
  11.4.2 Mylan Female Contraceptives Product Offered
  11.4.3 Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Mylan Main Business Overview
  11.4.5 Mylan Latest Developments
11.5 Teva
  11.5.1 Teva Company Information
  11.5.2 Teva Female Contraceptives Product Offered
  11.5.3 Teva Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Teva Main Business Overview
  11.5.5 Teva Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Female Contraceptives Product Offered
  11.6.3 Merck Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Johnson & Johnson
  11.7.1 Johnson & Johnson Company Information
  11.7.2 Johnson & Johnson Female Contraceptives Product Offered
  11.7.3 Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Johnson & Johnson Main Business Overview
  11.7.5 Johnson & Johnson Latest Developments
11.8 Lupin Pharmaceuticals
  11.8.1 Lupin Pharmaceuticals Company Information
  11.8.2 Lupin Pharmaceuticals Female Contraceptives Product Offered
  11.8.3 Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Lupin Pharmaceuticals Main Business Overview
  11.8.5 Lupin Pharmaceuticals Latest Developments
11.9 Female Health Company
  11.9.1 Female Health Company Company Information
  11.9.2 Female Health Company Female Contraceptives Product Offered
  11.9.3 Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Female Health Company Main Business Overview
  11.9.5 Female Health Company Latest Developments
11.10 Fuji Latex
  11.10.1 Fuji Latex Company Information
  11.10.2 Fuji Latex Female Contraceptives Product Offered
  11.10.3 Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Fuji Latex Main Business Overview
  11.10.5 Fuji Latex Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Female Contraceptives Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Female Contraceptives Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Contraceptive Drugs
Table 4. Major Players of Contraceptive Devices
Table 5. Female Contraceptives Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Female Contraceptives Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Female Contraceptives Market Size Market Share by Type (2020-2025)
Table 8. Female Contraceptives Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Female Contraceptives Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Female Contraceptives Market Size Market Share by Application (2020-2025)
Table 11. Global Female Contraceptives Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Female Contraceptives Revenue Market Share by Player (2020-2025)
Table 13. Female Contraceptives Key Players Head office and Products Offered
Table 14. Female Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Female Contraceptives Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Female Contraceptives Market Size Market Share by Region (2020-2025)
Table 19. Global Female Contraceptives Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Female Contraceptives Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Female Contraceptives Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Female Contraceptives Market Size Market Share by Country (2020-2025)
Table 23. Americas Female Contraceptives Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Female Contraceptives Market Size Market Share by Type (2020-2025)
Table 25. Americas Female Contraceptives Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Female Contraceptives Market Size Market Share by Application (2020-2025)
Table 27. APAC Female Contraceptives Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Female Contraceptives Market Size Market Share by Region (2020-2025)
Table 29. APAC Female Contraceptives Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Female Contraceptives Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Female Contraceptives Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Female Contraceptives Market Size Market Share by Country (2020-2025)
Table 33. Europe Female Contraceptives Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Female Contraceptives Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Female Contraceptives Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Female Contraceptives Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Female Contraceptives Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Female Contraceptives
Table 39. Key Market Challenges & Risks of Female Contraceptives
Table 40. Key Industry Trends of Female Contraceptives
Table 41. Global Female Contraceptives Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Female Contraceptives Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Female Contraceptives Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Female Contraceptives Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bayer Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 46. Bayer Female Contraceptives Product Offered
Table 47. Bayer Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bayer Main Business
Table 49. Bayer Latest Developments
Table 50. Mayer Laboratories Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 51. Mayer Laboratories Female Contraceptives Product Offered
Table 52. Mayer Laboratories Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Mayer Laboratories Main Business
Table 54. Mayer Laboratories Latest Developments
Table 55. Pfizer Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 56. Pfizer Female Contraceptives Product Offered
Table 57. Pfizer Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Mylan Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 61. Mylan Female Contraceptives Product Offered
Table 62. Mylan Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Mylan Main Business
Table 64. Mylan Latest Developments
Table 65. Teva Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 66. Teva Female Contraceptives Product Offered
Table 67. Teva Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Teva Main Business
Table 69. Teva Latest Developments
Table 70. Merck Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 71. Merck Female Contraceptives Product Offered
Table 72. Merck Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Merck Main Business
Table 74. Merck Latest Developments
Table 75. Johnson & Johnson Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 76. Johnson & Johnson Female Contraceptives Product Offered
Table 77. Johnson & Johnson Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Johnson & Johnson Main Business
Table 79. Johnson & Johnson Latest Developments
Table 80. Lupin Pharmaceuticals Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 81. Lupin Pharmaceuticals Female Contraceptives Product Offered
Table 82. Lupin Pharmaceuticals Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Lupin Pharmaceuticals Main Business
Table 84. Lupin Pharmaceuticals Latest Developments
Table 85. Female Health Company Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 86. Female Health Company Female Contraceptives Product Offered
Table 87. Female Health Company Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Female Health Company Main Business
Table 89. Female Health Company Latest Developments
Table 90. Fuji Latex Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 91. Fuji Latex Female Contraceptives Product Offered
Table 92. Fuji Latex Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Fuji Latex Main Business
Table 94. Fuji Latex Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Female Contraceptives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Female Contraceptives Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Female Contraceptives Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Female Contraceptives Sales Market Share by Country/Region (2024)
Figure 8. Female Contraceptives Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Female Contraceptives Market Size Market Share by Type in 2024
Figure 10. Female Contraceptives in Personal use
Figure 11. Global Female Contraceptives Market: Personal use (2020-2025) & ($ millions)
Figure 12. Female Contraceptives in Hospital
Figure 13. Global Female Contraceptives Market: Hospital (2020-2025) & ($ millions)
Figure 14. Global Female Contraceptives Market Size Market Share by Application in 2024
Figure 15. Global Female Contraceptives Revenue Market Share by Player in 2024
Figure 16. Global Female Contraceptives Market Size Market Share by Region (2020-2025)
Figure 17. Americas Female Contraceptives Market Size 2020-2025 ($ millions)
Figure 18. APAC Female Contraceptives Market Size 2020-2025 ($ millions)
Figure 19. Europe Female Contraceptives Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Female Contraceptives Market Size 2020-2025 ($ millions)
Figure 21. Americas Female Contraceptives Value Market Share by Country in 2024
Figure 22. United States Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Female Contraceptives Market Size Market Share by Region in 2024
Figure 27. APAC Female Contraceptives Market Size Market Share by Type (2020-2025)
Figure 28. APAC Female Contraceptives Market Size Market Share by Application (2020-2025)
Figure 29. China Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 33. India Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Female Contraceptives Market Size Market Share by Country in 2024
Figure 36. Europe Female Contraceptives Market Size Market Share by Type (2020-2025)
Figure 37. Europe Female Contraceptives Market Size Market Share by Application (2020-2025)
Figure 38. Germany Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 39. France Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Female Contraceptives Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Female Contraceptives Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Female Contraceptives Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Female Contraceptives Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 52. APAC Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 53. Europe Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 55. United States Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 56. Canada Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 57. Mexico Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 58. Brazil Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 59. China Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 60. Japan Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 61. Korea Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 63. India Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 64. Australia Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 65. Germany Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 66. France Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 67. UK Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 68. Italy Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 69. Russia Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 70. Egypt Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 71. South Africa Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 72. Israel Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 73. Turkey Female Contraceptives Market Size 2026-2031 ($ millions)
Figure 74. Global Female Contraceptives Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Female Contraceptives Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Female Contraceptives Market Size 2026-2031 ($ millions)